Imatinib mesylate accelerates follicle death andis not protective against chemotherapy induced damage in human ovary

2024-11-0920160015-028210.1016/j.fertnstert.2016.07.238http://dx.doi.org/10.1016/j.fertnstert.2016.07.238https://hdl.handle.net/20.500.14288/12603N/AObstetricsGynecologyReproductive biologyImatinib mesylate accelerates follicle death andis not protective against chemotherapy induced damage in human ovaryMeeting Abstract1556-5653449962500201Q1944